Pharmacovigilance Programme of India: Recent developments and future perspectives

Promoting safe use of medicines is a priority of Indian Pharmacopoeia Commission that functions as the National Coordination Center (NCC) for Pharmacovigilance Programme of India (PvPI). One hundred and seventy-nine adverse drug reactions (ADRs) monitoring centers currently report ADRs to NCC. Curre...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalaiselvan, Vivekanandan, Thota, Prasad, Singh, Gyanendra Nath
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Educational Forum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5155460/
https://www.ncbi.nlm.nih.gov/pubmed/28066097
http://dx.doi.org/10.4103/0253-7613.194855

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5155460/
https://www.ncbi.nlm.nih.gov/pubmed/28066097
http://dx.doi.org/10.4103/0253-7613.194855

Ejemplares similares